Expression of GPR56 in Glioblastoma (GBM) was found to be heterogeneous, with the heterogeneity arising from expression of the receptor in spatially different tumor tissue and cell types (high in proliferating cells and low in hypoxic mesenchymal cells). This evidence concerns the gene ADGRG1 and neoplasm.